Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. AAMDSIF Summer Fellowship Grant Program

    ... aplastic anemia ,’ investigating how CD4 and CD8 T cells interact to influence bone marrow failure . She described ... failure are largely unknown. T cells, one type of immune cell, have long been known to be expanded in the bone marrow of aplastic anemia ...

    Page last updated 05/17/2017 - 1:29pm.

  2. Total Marrow Irradiation for Refractory Acute Leukemia

    ... a donor umbilical cord blood or hematopoietic stem cell transplant helps stop the growth of cancer cells. It may also stop the ... or not in remission (pediatric patients <18 years) T cell leukemia ≥ CR2 Evidence of pre-transplant minimal residual ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  3. Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC (ExpMACs)

    ... and who are candidates for allogeneic hematopoietic stem cell transplant (HSCT). These patients have a serious or immediately ... IRB approved protocols that utilize CliniMACs technology for T depletion. Status:  ...

    Clinical Trial last updated 06/13/2016 - 1:47pm.

  4. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... non-Hodgkin's lymphoma (NHL), including diffuse large cell lymphoma, mediastinal B-cell lymphoma, transformed lymphoma, mantle cell lymphoma, and peripheral T cell lymphoma, who also have one of the disease features as described in ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  5. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... non-Hodgkin's lymphoma (NHL), including diffuse large cell lymphoma, mediastinal B-cell lymphoma, transformed lymphoma, mantle cell lymphoma, and peripheral T cell lymphoma, who also have one of the disease features as described in ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  6. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

    ... called multiple tumor-associated antigen (TAA)-specific T cells (a new experimental therapy) to treat patients with acute myeloid ... treatment, including an allogeneic hematopoietic stem cell transplant (HSCT). The investigators have previously used this ...

    Clinical Trial last updated 04/28/2016 - 11:40am.

  7. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... malignancies undergoing donor peripheral blood stem cell (PBSC) transplant. Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the ... T 586 Other: Laboratory Biomarker Analysis Correlative studies Drug: ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  8. Chronic Myelomonocytic Leukemia (CMML)

    ... bone marrow. But other factors associated with CMML didn't match the definition of MDS. Instead, they more closely resembled ... is having too many monocytes, a type of white blood cell , in the blood. These cells can settle in the liver and spleen, causing ...

    Topic section last updated 12/16/2016 - 9:42am.

  9. FAQs

    ... families. Just click on the question to view the answer. Don't see the answer to your question here? Send your question to our patient ... MDS, you must have low blood counts for at least one blood cell type and your blood cells must look abnormal under a microscope. Doctors ...

    Topic section last updated 03/02/2016 - 11:42am.

  10. Resources to Help

    ... the needs of patients facing a  bone marrow , blood stem cell or umbilical  cord blood transplant . In addition to high-quality ... the standard advanced care planning documents don’t meet all the needs of younger patients. This study found that adolescents and ...

    Topic section last updated 09/28/2017 - 11:58am.